An Egr-1-specific DNAzyme regulates Egr-1 and proliferating cell nuclear antigen expression in rat vascular smooth muscle cells.

about

An Egr-1-specific DNAzyme regulates Egr-1 and proliferating cell nuclear antigen expression in rat vascular smooth muscle cells.

Item

http://www.wikidata.org/entity/Q41482681

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

An Egr-1-specific DNAzyme regu ...... vascular smooth muscle cells.

@en

type

Item

label

An Egr-1-specific DNAzyme regu ...... vascular smooth muscle cells.

@en

prefLabel

An Egr-1-specific DNAzyme regu ...... vascular smooth muscle cells.

@en

P1476

An Egr-1-specific DNAzyme regu ...... vascular smooth muscle cells.

@en

P2093

Bing Sun

http://www.w3.org/2001/XMLSchema#string

Changlei Guo

http://www.w3.org/2001/XMLSchema#string

Junbiao Zhang

http://www.w3.org/2001/XMLSchema#string

Luli Huang

http://www.w3.org/2001/XMLSchema#string

Ran Wang

http://www.w3.org/2001/XMLSchema#string

Runnan Liu

http://www.w3.org/2001/XMLSchema#string

Wanqian Liang

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasia.

Prevention of coronary restenosis.

Early growth response-1 in cardiovascular pathobiology.

Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent.

High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia.

EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat.

Identification and characterization of functional angiotensin II type 1 receptors on immortalized human fetal aortic vascular smooth muscle cells.

Characterization of a DNA-cleaving deoxyribozyme.

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.

P304

1371-1374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2013.1013

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237057857

http://www.w3.org/2001/XMLSchema#string

P698

23737882

http://www.w3.org/2001/XMLSchema#string

P932

3671740

http://www.w3.org/2001/XMLSchema#string